{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:21:24Z","timestamp":1791328884394,"version":"4.3.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.mce.2011.07.035","type":"journal-article","created":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T11:51:38Z","timestamp":1311767498000},"page":"187-195","source":"Crossref","is-referenced-by-count":56,"title":["Structural determinants of ligand binding to the mineralocorticoid receptor"],"prefix":"10.1016","volume":"350","author":[{"given":"Jessica","family":"Huyet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory Maurice","family":"Pinon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel Raymond","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Edith","family":"Rafestin-Oblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Fagart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2011.07.035_b0005","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1021\/jm100506y","article-title":"Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonists","volume":"53","author":"Arhancet","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mce.2011.07.035_b0010","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1124\/mol.58.4.684","article-title":"A single amino acid mutation of ala-773 in the mineralocorticoid receptor confers agonist properties to 11beta-substituted spirolactones","volume":"58","author":"Auzou","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mce.2011.07.035_b0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0092-8674(02)00817-6","article-title":"Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition","volume":"110","author":"Bledsoe","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.mce.2011.07.035_b0020","doi-asserted-by":"crossref","first-page":"31283","DOI":"10.1074\/jbc.M504098200","article-title":"A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor","volume":"280","author":"Bledsoe","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2011.07.035_b0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0960-0760(03)00036-0","article-title":"Glucocorticoid metabolism by 11-beta hydroxysteroid dehydrogenase type 2 modulates human mineralocorticoid receptor transactivation activity","volume":"84","author":"Bocchi","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.07.035_b0030","first-page":"S49","article-title":"Regulation of sodium transport by steroid hormones","volume":"65","author":"Bonvalet","year":"1998","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.mce.2011.07.035_b0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/375377a0","article-title":"Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha","volume":"375","author":"Bourguet","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.mce.2011.07.035_b0040","doi-asserted-by":"crossref","first-page":"8589","DOI":"10.1021\/bi00084a028","article-title":"A bacterially expressed mineralocorticoid receptor is associated in vitro with the 90-kilodalton heat shock protein and shows typical hormone- and DNA-binding characteristics","volume":"32","author":"Caamano","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2011.07.035_b0045","first-page":"691","article-title":"Sexual side-effects of spironolactones. Possible mechanisms of their anti-androgen action","volume":"5","author":"Corvol","year":"1976","journal-title":"Nouv. Presse Med."},{"key":"10.1016\/j.mce.2011.07.035_b0050","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1042\/bj3150421","article-title":"Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure","volume":"315","author":"Couette","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.mce.2011.07.035_b0055","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1210\/me.12.6.855","article-title":"Folding requirements of the ligand-binding domain of the human mineralocorticoid receptor","volume":"12","author":"Couette","year":"1998","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.07.035_b0060","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","article-title":"Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro","volume":"240","author":"De Gasparo","year":"1986","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.mce.2011.07.035_b0065","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/HYPERTENSIONAHA.107.103580","article-title":"A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity","volume":"51","author":"Dietz","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2011.07.035_b0070","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1093\/emboj\/17.12.3317","article-title":"Antagonism in the human mineralocorticoid receptor","volume":"17","author":"Fagart","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.mce.2011.07.035_b0075","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1124\/mol.104.010710","article-title":"The Met852 residue is a key organizer of the ligand-binding cavity of the human mineralocorticoid receptor","volume":"67","author":"Fagart","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mce.2011.07.035_b0080","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nsmb939","article-title":"Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension","volume":"12","author":"Fagart","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.mce.2011.07.035_b0085","doi-asserted-by":"crossref","first-page":"29932","DOI":"10.1074\/jbc.M110.131342","article-title":"A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule","volume":"285","author":"Fagart","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2011.07.035_b0090","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.HYP.0000193502.77417.17","article-title":"Mechanisms of mineralocorticoid action","volume":"46","author":"Fuller","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2011.07.035_b0095","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1210\/me.14.6.889","article-title":"Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1)","volume":"14","author":"Fuse","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.07.035_b0100","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/MCB.01190-09","article-title":"The hsp90-FKBP52 complex links the mineralocorticoid receptor to motor proteins and persists bound to the receptor in early nuclear events","volume":"30","author":"Galigniana","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mce.2011.07.035_b0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mce.2003.10.005","article-title":"The evolution of aldosterone antagonists","volume":"217","author":"Garthwaite","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2011.07.035_b0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1126\/science.289.5476.119","article-title":"Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy","volume":"289","author":"Geller","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.mce.2011.07.035_b0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1107\/S0907444906047020","article-title":"Crystallization of protein-ligand complexes","volume":"63","author":"Hassell","year":"2007","journal-title":"Acta Crystallogr., D Biol. Crystallogr."},{"key":"10.1016\/j.mce.2011.07.035_b0120","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/42750","article-title":"A signature motif in transcriptional co-activators mediates binding to nuclear receptors","volume":"387","author":"Heery","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.mce.2011.07.035_b0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-5793(99)01667-1","article-title":"Specific hydroxylations determine selective corticosteroid recognition by human glucocorticoid and mineralocorticoid receptors","volume":"464","author":"Hellal-Levy","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mce.2011.07.035_b0130","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1046\/j.1523-1755.2000.00958.x","article-title":"Mechanistic aspects of mineralocorticoid receptor activation","volume":"57","author":"Hellal-Levy","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.mce.2011.07.035_b0135","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1210\/me.14.8.1210","article-title":"Crucial role of the H11\u2013H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor","volume":"14","author":"Hellal-Levy","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.07.035_b0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.HYP.19.3.221","article-title":"Aldosterone regulation of gene transcription leading to control of ion transport","volume":"19","author":"Horisberger","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2011.07.035_b0145","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1210\/me.2004-0537","article-title":"The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms","volume":"19","author":"Hultman","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.07.035_b0150","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1124\/mol.107.036459","article-title":"Structural basis of spirolactone recognition by the mineralocorticoid receptor","volume":"72","author":"Huyet","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mce.2011.07.035_b0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0960-0760(95)00250-2","article-title":"Putative steroid binding domain of the human mineralocorticoid receptor, expressed in E. coli in the presence of heat shock proteins shows typical native receptor characteristics","volume":"57","author":"Jalaguier","year":"1996","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.07.035_b0160","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1128\/MCB.22.11.3698-3706.2002","article-title":"Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex","volume":"22","author":"Kitagawa","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mce.2011.07.035_b0165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2010.03.018","article-title":"The L-, N-, and T-type triple calcium channel blocker benidipine acts as an antagonist of mineralocorticoid receptor, a member of nuclear receptor family","volume":"635","author":"Kosaka","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.mce.2011.07.035_b0170","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/jcem-15-10-1194","article-title":"The metabolic effects of progesterone in man","volume":"15","author":"Landau","year":"1955","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.07.035_b0175","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.molcel.2005.06.026","article-title":"Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor","volume":"19","author":"Li","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mce.2011.07.035_b0180","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/bj3020191","article-title":"Differential intracellular localization of human mineralocorticosteroid receptor on binding of agonists and antagonists","volume":"302","author":"Lombes","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.mce.2011.07.035_b0185","first-page":"1583","article-title":"Mespirenone and other 15,16-methylene-17-spirolactones, a new type of steroidal aldosterone antagonists","volume":"36","author":"Losert","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.mce.2011.07.035_b0190","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/352497a0","article-title":"Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA","volume":"352","author":"Luisi","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.mce.2011.07.035_b0195","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1021\/jm100505n","article-title":"Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g] indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy","volume":"53","author":"Meyers","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mce.2011.07.035_b0200","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0955-0674(98)80015-X","article-title":"The nuclear receptor ligand-binding domain: structure and function","volume":"10","author":"Moras","year":"1998","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.mce.2011.07.035_b0205","doi-asserted-by":"crossref","first-page":"8084","DOI":"10.1074\/jbc.M109.053371","article-title":"NF\u2013YC functions as a corepressor of agonist-bound mineralocorticoid receptor","volume":"285","author":"Murai-Takeda","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2011.07.035_b0210","unstructured":"Nedelec, L., Philibert, D., Torelli, V., 1986. Recent developments in the field of steroid antihormones. Third SCI-RSC Med. Chem. Sympo. 322\u2013344."},{"key":"10.1016\/j.mce.2011.07.035_b0215","first-page":"769","article-title":"Dual roles of 90-kDa heat shock protein in the function of the mineralocorticoid receptor","volume":"113","author":"Nemoto","year":"1993","journal-title":"J. Biochem. (Tokyo)"},{"key":"10.1016\/j.mce.2011.07.035_b0220","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.1142819","article-title":"Crystal structure of an ancient protein: evolution by conformational epistasis","volume":"317","author":"Ortlund","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.mce.2011.07.035_b0225","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.mce.2003.10.053","article-title":"Identification of steroid ligands able to inactivate the mineralocorticoid receptor harboring the S810L mutation responsible for a severe form of hypertension","volume":"217","author":"Pinon","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2011.07.035_b0230","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/me.2009-0032","article-title":"Structural and functional characterization of the interdomain interaction in the mineralocorticoid receptor","volume":"23","author":"Pippal","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.07.035_b0235","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mce.2010.09.014","article-title":"Characterization of the zebrafish (Danio rerio) mineralocorticoid receptor","volume":"332","author":"Pippal","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2011.07.035_b0240","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2011.07.035_b0245","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2011.07.035_b0250","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0022-4731(77)90211-4","article-title":"Dramatic protective effect of ligand against thermal degradation on mineraloand glucocorticoid receptors of rat kidney","volume":"8","author":"Rafestin-Oblin","year":"1977","journal-title":"J. Steroid. Biochem."},{"key":"10.1016\/j.mce.2011.07.035_b0255","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1016\/S0021-9258(18)60531-9","article-title":"Mineralocorticosteroid receptor of the chick intestine. Oligomeric structure and transformation","volume":"264","author":"Rafestin-Oblin","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2011.07.035_b0260","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0960-0760(92)90430-Q","article-title":"Differences between aldosterone and its antagonists in binding kinetics and ligand-induced hsp90 release from mineralocorticosteroid receptor","volume":"41","author":"Rafestin-Oblin","year":"1992","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.07.035_b0265","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1124\/mol.62.6.1306","article-title":"11Beta-hydroxyprogesterone acts as a mineralocorticoid agonist in stimulating Na+ absorption in mammalian principal cortical collecting duct cells","volume":"62","author":"Rafestin-Oblin","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mce.2011.07.035_b0270","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1210\/en.2002-220708","article-title":"The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related","volume":"144","author":"Rafestin-Oblin","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2011.07.035_b0275","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/378681a0","article-title":"Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid","volume":"378","author":"Renaud","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.mce.2011.07.035_b0280","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1210\/me.7.9.1226","article-title":"Demonstration of nuclear translocation of the mineralocorticoid receptor (MR) using an anti-MR antibody and confocal laser scanning microscopy","volume":"7","author":"Robertson","year":"1993","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.07.035_b0285","doi-asserted-by":"crossref","first-page":"36305","DOI":"10.1074\/jbc.274.51.36305","article-title":"Structural determinants of aldosterone binding selectivity in the mineralocorticoid receptor","volume":"274","author":"Rogerson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2011.07.035_b0290","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0303-7207(02)00413-6","article-title":"Interdomain interactions in the mineralocorticoid receptor","volume":"200","author":"Rogerson","year":"2003","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2011.07.035_b0295","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1210\/me.2006-0246","article-title":"A critical region in the mineralocorticoid receptor for aldosterone binding and activation by cortisol: evidence for a common mechanism governing ligand binding specificity in steroid hormone receptors","volume":"21","author":"Rogerson","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.07.035_b0300","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tem.2005.02.010","article-title":"Aldosterone as a cardiovascular risk factor","volume":"16","author":"Rossi","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.07.035_b0305","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0922-4106(93)90072-H","article-title":"Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands","volume":"247","author":"Rupprecht","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.mce.2011.07.035_b0310","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1210\/me.2003-0408","article-title":"New naturally occurring missense mutations of the human mineralocorticoid receptor disclose important residues involved in dynamic interactions with deoxyribonucleic acid, intracellular trafficking, and ligand binding","volume":"18","author":"Sartorato","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.07.035_b0315","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1210\/me.2008-0089","article-title":"The intersection of steroid receptors with molecular chaperones: observations and questions","volume":"22","author":"Smith","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.07.035_b0320","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1210\/en.136.12.5651","article-title":"The mineralocorticoid activity of progesterone derivatives depends on the nature of the C18 substituent","volume":"136","author":"Souque","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2011.07.035_b0325","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0960-0760(95)00278-2","article-title":"Sulfhydryl groups are involved in the binding of agonists and antagonists to the human mineralocorticoid receptor","volume":"57","author":"Souque","year":"1996","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.07.035_b0330","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/me.2003-0299","article-title":"Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification","volume":"17","author":"Tallec","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.07.035_b0335","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nsb0196-87","article-title":"A canonical structure for the ligand-binding domain of nuclear receptors","volume":"3","author":"Wurtz","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.mce.2011.07.035_b0340","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1677\/JME-09-0031","article-title":"The mineralocorticoid receptor and its coregulators","volume":"43","author":"Yang","year":"2009","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.07.035_b0345","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/me.2010-0193","article-title":"Identification of ligand-selective peptide antagonists of the mineralocorticoid receptor using phage display","volume":"25","author":"Yang","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.07.035_b0350","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"EMPHASIS-HF Study Group, 2011. Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N. Engl. J. Med."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720711004345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720711004345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T20:24:54Z","timestamp":1741379094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720711004345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0303720711004345"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2011.07.035","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}